International Stem Cell CORP financial data

Symbol
ISCO on OTC
Location
9745 Businesspark Avenue, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 77.2 % +4.61%
Quick Ratio 28.6 % +4.8%
Debt-to-equity -128 % -1.55%
Return On Equity 1.5 % -90.8%
Return On Assets -1.09 % +91.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8M shares 0%
Common Stock, Shares, Outstanding 8M shares 0%
Entity Public Float 222K USD -53.8%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 8M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 8.17M shares +2.04%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.39M USD +10.1%
Cost of Revenue 3.96M USD +8.8%
Research and Development Expense 717K USD +17%
Selling and Marketing Expense 1.13M USD -9.7%
General and Administrative Expense 3.49M USD -2.24%
Costs and Expenses 9.29M USD +2.46%
Operating Income (Loss) 97K USD
Nonoperating Income (Expense) -156K USD -15.6%
Net Income (Loss) Attributable to Parent -59K USD +91.3%
Earnings Per Share, Basic 0 USD/shares +85.7%
Earnings Per Share, Diluted 0 USD/shares +85.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 1.02M USD +49.3%
Inventory, Net 1.59M USD +15%
Other Assets, Current 7K USD -30%
Assets, Current 3.73M USD +6.99%
Property, Plant and Equipment, Net 192K USD -33.8%
Operating Lease, Right-of-Use Asset 425K USD +4.42%
Intangible Assets, Net (Excluding Goodwill) 661K USD -10.6%
Assets 5.28M USD +1.97%
Accounts Payable, Current 265K USD -17.4%
Accrued Liabilities, Current 452K USD -4.84%
Liabilities, Current 4.66M USD -1.34%
Operating Lease, Liability, Noncurrent 103K USD -49.3%
Liabilities 4.76M USD -3.31%
Retained Earnings (Accumulated Deficit) -111M USD -0.05%
Stockholders' Equity Attributable to Parent -3.78M USD +6.56%
Liabilities and Equity 5.28M USD +1.97%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 227K USD
Net Cash Provided by (Used in) Investing Activities -5K USD +44.4%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 8M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 222K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 966K USD -26.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3K USD 0%
Deferred Tax Assets, Valuation Allowance 7.56M USD -3.83%
Deferred Tax Assets, Gross 7.67M USD -4.35%
Operating Lease, Liability 486K USD -6.18%
Payments to Acquire Property, Plant, and Equipment 5K USD -37.5%
Lessee, Operating Lease, Liability, to be Paid 515K USD -9.17%
Property, Plant and Equipment, Gross 2.62M USD -0.23%
Operating Lease, Liability, Current 383K USD +21.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 119K USD -66.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 412K USD +14.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure -7.58%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29K USD -40.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 119K USD -66.9%
Deferred Tax Assets, Operating Loss Carryforwards 5.21M USD -4.89%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 478K USD 0%
Additional Paid in Capital 107M USD +0.3%
Amortization of Intangible Assets 80K USD -3.61%
Depreciation, Depletion and Amortization 219K USD +5.66%
Deferred Tax Assets, Net of Valuation Allowance 109K USD -30.6%
Share-based Payment Arrangement, Expense 324K USD -34.7%
Interest Expense 37K USD +5.71%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%